Join
Live feed
·
PRReleasevia Quantisnow
SciSparc Ltd. logo
Clearmind Medicine Inc. logo

SciSparc: Subsidiary NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine and Ibogaine Combinations

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SPRC (SciSparc Ltd.), CMND (Clearmind Medicine Inc.) and more on Quantisnow.